SCHEMBL20156244

SCHEMBL20156244

CCOC(=O)/C(=C/NCCC(C)=O)C(=N)C(F)(F)F

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 3/20 0.44
ALDH1A1 P00352 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
NPSR1 Q6W5P4 4/20 0.39
GLO1 Q04760 1/20 0.38
DHODH Q02127 3/20 0.34
LMNA P02545 2/20 0.33
MAPK1 P28482 2/20 0.33
KDM4E B2RXH2 2/20 0.33
GAA P10253 3/20 0.33
MAPT P10636 3/20 0.33
TDP1 Q9NUW8 1/20 0.33
MEN1 O00255 4/20 0.32
KMT2A Q03164 4/20 0.32
CYP1A2 P05177 2/20 0.32
CYP2C19 P33261 2/20 0.32
CYP2C9 P11712 1/20 0.32
CYP3A4 P08684 2/20 0.32
POLB P06746 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20156241 0.79 ALDH1A1 (0.38) CYP2D6ALDH1A1SMN1; SMN2NPSR1GLO1
SCHEMBL20156302 0.78 CYP2D6 (0.41) CYP2D6ALDH1A1SMN1; SMN2NPSR1GLO1
SCHEMBL20156006 0.76 ALDH1A1 (0.39) CYP2D6ALDH1A1SMN1; SMN2NPSR1GLO1
SCHEMBL14391944 0.73 NPSR1 (0.43) CYP2D6ALDH1A1SMN1; SMN2NPSR1GLO1
SCHEMBL13958022 0.73 NPSR1 (0.43) CYP2D6ALDH1A1SMN1; SMN2NPSR1GLO1
SCHEMBL20156243 0.72 MAPT (0.41) CYP2D6NPSR1DHODHMAPK1KDM4E
SCHEMBL20156348 0.71 CYP2D6 (0.40) CYP2D6ALDH1A1SMN1; SMN2NPSR1GLO1
SCHEMBL19403663 0.70 HDAC4 (0.41) ALDH1A1NPSR1GLO1LMNAGAA
SCHEMBL24303814 0.69 NPSR1 (0.62) CYP2D6ALDH1A1NPSR1DHODHLMNA
SCHEMBL23912850 0.68 ALDH1A1 (0.37) CYP2D6ALDH1A1SMN1; SMN2NPSR1GLO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018089358-A1 AZOLE AMIDES AND AMINES AS ALPHA V INTEGRIN INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2018-05-17 WO disclosed